CA2613178A1 — Sustained release preparation
Assigned to Kissei Pharmaceutical Co Ltd · Expires 2007-01-25 · 19y expired
What this patent protects
[PROBLEMS] To provide a preparation which shows a satisfactory gastric residence time, has such a size that is easy to be ingested, can be disintegrated rapidly after the excretion from the stomach, and can be prepared readily in an industrial scale. [MEANS FOR SOLVING PROBLEMS] …
USPTO Abstract
[PROBLEMS] To provide a preparation which shows a satisfactory gastric residence time, has such a size that is easy to be ingested, can be disintegrated rapidly after the excretion from the stomach, and can be prepared readily in an industrial scale. [MEANS FOR SOLVING PROBLEMS] A gastric retentive preparation having a gastric resident layer and a drug release layer, wherein the gastric resident layer is never disintegrated in the stomach and is disintegrated in the intestine. Preferably, the gastric resident layer shows the minimum diameter of 7 mm or more as measured after stirring the preparation in a first solution at 200 rpm at 37~C for 15 hours under the conditions for the paddle method in the dissolution test in accordance with Japanese Pharmacopoeia and shows the maximum diameter of 6 mm or less as measured after further stirring the preparation in a second solution at 200 rpm at 37~C for 9 hours under the same conditions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.